Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Regulation FD disclosure · Other events
  3. 8-K Event Other events
  4. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 8-K Event Other events
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Material agreement · Results of operations · Regulation FD disclosure
  13. 424B5 Offering Prospectus
  14. 10-Q Report Quarterly Report
  15. 8-K Event Other events
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. NT 10-Q Other NT 10-Q
  18. RW Other RW
  19. UPLOAD Other SEC-generated Letter
  20. S-3 Offering Registration Statement

Page 3 of 24 · 479 filings